Samsung Bioepis Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for OS ...
Researchers say study provides sufficient rationale to further explore the therapeutic uses of SSRIs during infection.
Researchers say study provides sufficient rationale to further explore the therapeutic uses of SSRIs during infection.
A recent drug discovery could eventually help the visually impaired and those suffering from multiple sclerosis, traumatic stroke, and Alzheimer’s disease regain some of their vision and mental ...
Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s,” Charles Piller looks how the amyloid hypothesis took over ...
U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new ...
Authors Table of Contents Media Contact For general and media inquiries and to book our experts, please contact: ...
Researchers create new compound to potentially treat negative and positive symptoms of schizophrenia
We often think about diseases in terms of the symptoms they present. A cold might give you the sniffles or even GI distress, while malaria can give you fever, chills, or nausea, for example. These ...
Peripartum cardiac insufficiency (PPCM) is a rare but life-threatening condition that can affect previously heart-healthy ...
A joint research team from the LKS Faculty of Medicine (HKUMed) and the Faculty of Science at the University of Hong Kong has uncovered an unexpected interaction between chemotherapeutic agents and a ...
Company completed Type C meeting with FDA, aligning on its plan to submit an sNDA; submission expected around end of 1Q25. If approved, FILSPARI could be the first and only approv ...
A groundbreaking study suggests that IBS might be more of a brain issue than a gut disorder. Researchers found that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results